PKC alpha inhibitor (eXegenics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePKC alpha inhibitor (eXegenics)
Drug Alias Nameantisense inhibitor (Cytoclonal)PKC alpha inhibitor (Cytoclonal)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpko Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpko Health Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A